81 related articles for article (PubMed ID: 23270673)
1. Plasma visfatin, associated with a genetic polymorphism -1535C>T, is correlated with C-reactive protein in Chinese Han patients with traumatic brain injury.
Weng JF; Chen J; Hong WC; Luo LF; Yu W; Luo SD
Peptides; 2013 Feb; 40():8-12. PubMed ID: 23270673
[TBL] [Abstract][Full Text] [Related]
2. Genetic variant in visfatin gene promoter is associated with decreased risk of coronary artery disease in a Chinese population.
Yan JJ; Tang NP; Tang JJ; Jia EZ; Wang MW; Wang QM; Zhu J; Yang ZJ; Wang LS; Huang J
Clin Chim Acta; 2010 Jan; 411(1-2):26-30. PubMed ID: 19804767
[TBL] [Abstract][Full Text] [Related]
3. A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery disease.
Wang LS; Yan JJ; Tang NP; Zhu J; Wang YS; Wang QM; Tang JJ; Wang MW; Jia EZ; Yang ZJ; Huang J
Mol Biol Rep; 2011 Feb; 38(2):819-25. PubMed ID: 20383745
[TBL] [Abstract][Full Text] [Related]
4. Change in plasma visfatin level after severe traumatic brain injury.
Chen J; Weng JF; Hong WC; Luo LF; Yu W; Luo SD
Peptides; 2012 Nov; 38(1):8-12. PubMed ID: 22960047
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
[TBL] [Abstract][Full Text] [Related]
6. Elevated visfatin/pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke.
Lu LF; Yang SS; Wang CP; Hung WC; Yu TH; Chiu CA; Chung FM; Shin SJ; Lee YJ
J Stroke Cerebrovasc Dis; 2009; 18(5):354-9. PubMed ID: 19717018
[TBL] [Abstract][Full Text] [Related]
7. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
[TBL] [Abstract][Full Text] [Related]
8. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
[TBL] [Abstract][Full Text] [Related]
9. Elevated visfatin levels in obese children are related to proinflammatory factors.
Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
[TBL] [Abstract][Full Text] [Related]
10. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
Caixàs A; Tirado R; Vendrell J; Gallart L; Megía A; Simón I; Llauradó G; González-Clemente JM; Giménez-Palop O
Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486
[TBL] [Abstract][Full Text] [Related]
11. Effect of a hypocaloric diet on serum visfatin in obese non-diabetic patients.
de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O; Romero E
Nutrition; 2008 Jun; 24(6):517-21. PubMed ID: 18343636
[TBL] [Abstract][Full Text] [Related]
12. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
Oki K; Yamane K; Kamei N; Nojima H; Kohno N
Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
[TBL] [Abstract][Full Text] [Related]
13. The -1535 promoter variant of the visfatin gene is associated with serum triglyceride and HDL-cholesterol levels in Japanese subjects.
Tokunaga A; Miura A; Okauchi Y; Segawa K; Fukuhara A; Okita K; Takahashi M; Funahashi T; Miyagawa J; Shimomura I; Yamagata K
Endocr J; 2008 Mar; 55(1):205-12. PubMed ID: 18270432
[TBL] [Abstract][Full Text] [Related]
14. In-vitro function of upstream visfatin polymorphisms that are associated with adverse cardiometabolic parameters in obese children.
Ooi DS; Ong SG; Heng CK; Loke KY; Lee YS
BMC Genomics; 2016 Nov; 17(1):974. PubMed ID: 27887573
[TBL] [Abstract][Full Text] [Related]
15. High concentrations of visfatin in the peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome.
Huang Q; Dai WM; Jie YQ; Yu GF; Fan XF; Wu A
Peptides; 2013 Jan; 39():55-8. PubMed ID: 23174347
[TBL] [Abstract][Full Text] [Related]
16. Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers.
Bo S; Ciccone G; Baldi I; Gambino R; Mandrile C; Durazzo M; Gentile L; Cassader M; Cavallo-Perin P; Pagano G
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):423-30. PubMed ID: 19073361
[TBL] [Abstract][Full Text] [Related]
17. Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance.
Gen R; Akbay E; Muslu N; Sezer K; Cayan F
Gynecol Endocrinol; 2009 Apr; 25(4):241-5. PubMed ID: 19408173
[TBL] [Abstract][Full Text] [Related]
18. Preliminary study of the level of visfatin and the relationship with insulin resistance in Chinese patients with chronic hepatitis C.
Wang Y; Chen J; Pan J; Zhang W; Chen Z; Yu F
Arch Iran Med; 2013 Feb; 16(2):74-7. PubMed ID: 23360627
[TBL] [Abstract][Full Text] [Related]
19. Circulating visfatin in chronic obstructive pulmonary disease.
Liu X; Ji Y; Chen J; Li S; Luo F
Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients.
Kang YS; Song HK; Lee MH; Ko GJ; Cha DR
Diabetes Res Clin Pract; 2010 Aug; 89(2):141-9. PubMed ID: 20409603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]